1070 Differential Expression of MicroRNAs in Plasma of Colorectal Cancer Patients: A Potential Marker for Colorectal Cancer Screening

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Gastroenterology

• Publication date

  2009-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0016-5085(09)60743-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.

  2008cited by this paper
• E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.

  2008cited by this paper
• Detection and characterization of placental microRNAs in maternal plasma.

  2008cited by this paper
• Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

  2008cited by this paper
• MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

  2008cited by this paper
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

  2007cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• Risk Factors Associated with Acute Pyelonephritis in Healthy Women

  2005cited by this paper
• Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients.

  2004cited by this paper
• Colorectal cancer screening: scientific review.

  2003cited by this paper
• Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

  2002cited by this paper
• Telomerase RNA as a detection marker in the serum of breast cancer patients.

  2000cited by this paper

• Machine Learning Perspective in Cancer Research

  2021cites this paper
• Concomitant Up-Regulation of Hsa- Mir-374 and Down-Regulation of Its Targets, GSK-3β and APC, in Tissue Samples of Colorectal Cancer.

  2021cites this paper
• A Systematic Review of Applications of Machine Learning in Cancer Prediction and Diagnosis

  2021cites this paper
• Clinical relevance and functional significance of cell-free microRNA-1260b expression profiles in infiltrative myxofibrosarcoma

  2020cites this paper
• Direct S-Poly(T) Plus assay in quantification of microRNAs without RNA extraction and its implications in colorectal cancer biomarker studies

  2019cites this paper
• MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.

  2018cites this paper
• Ribonucleic-acid-biomarker candidates for early-phase group detection of common cancers.

  2018cites this paper
• Novel biotechnology approaches in colorectal cancer diagnosis and therapy

  2017cites this paper
• A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression

  2017cites this paper
• Regulation of miRNAs by herbal medicine: An emerging field in cancer therapies.

  2017cites this paper
• miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4

  2017cites this paper
• Epigenetic biomarkers in colorectal cancer: premises and prospects

  2016cites this paper
• Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).

  2015cites this paper
• Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.

  2015cites this paper
• Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients

  2014cites this paper
• MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis

  2014cites this paper
• The Application of MicroRNAs in Cancer Diagnostics

  2013cites this paper
• Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer

  2013influential citation
• Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.

  2012cites this paper
• MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.

  2012cites this paper
• Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection

  2012cites this paper
• Serum microRNA-155 as a potential biomarker for breast cancer screening

  2012cites this paper
• Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma

  2012cites this paper
• Analysis of serum genome-wide microRNAs for breast cancer detection.

  2012cites this paper
• Alterations of microRNAs contribute to colon carcinogenesis.

  2011cites this paper
• MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease

  2011cites this paper
• Procédés analytiques pour acides nucléiques acellulaires et applications

  2011cites this paper
• Reduction of plasma MicroRNA-21 is associated with chemotherapeutic response in patients with non-small cell lung cancer

  2011cites this paper
• MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

  2011cites this paper
• MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.

  2011cites this paper
• miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis.

  2011cites this paper
• Emerging role of small ribonucleic acids in gastrointestinal tumors.

  2010cites this paper
• A Combination of Serum Markers for the Early Detection of Colorectal Cancer

  2010cites this paper
• Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels.

  2010cites this paper
• Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer

  2010cites this paper
• MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.

  2010cites this paper
• Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

  2010cites this paper
• miRNAs as biomarkers for management of patients with colorectal cancer.

  2010cites this paper
• Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival

  2010cites this paper
• MicroRNAs as biomarkers in colorectal cancer.

  2010cites this paper
• Serum microRNAs as powerful cancer biomarkers.

  2010cites this paper
• MicroRNAs: master regulators of ethanol abuse and toxicity?

  2010cites this paper
• Blood Tests for Early Detection of Colorectal Cancer

  2010cites this paper
• Detection, Profiling, and Quantification of miRNA Expression

  2010cites this paper
• MicroRNAs and cancer--new paradigms in molecular oncology.

  2009cites this paper
• MicroRNA Expression Detection Methods

  2009cites this paper
• MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.

  2009cites this paper
• Pathogenetic and clinical relevance of microRNAs in colorectal cancer.

  2009cites this paper
• MicroRNAs: tools for cancer diagnostics

  2009cites this paper
• MicroRNA dysregulation during chemical carcinogenesis.

  2009cites this paper
• Plasma microRNAs: a potential biomarker for colorectal cancer?

  2009cites this paper
• MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer

  2009cites this paper
• MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

  2009influential citation
• Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles?

  2009cites this paper
• MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases

  2009cites this paper